Tan A - Search Results

1

Adjuvant treatment after orthotopic liver transplantation: is it really necessary?

Kim R, Tan A, Estfan B, Aucejo F. Kim R, et al. Among authors: tan a. Oncology (Williston Park). 2009 Dec;23(14):1276-81. Oncology (Williston Park). 2009. PMID: 20120841 Free article.

2

What is the indication for sorafenib in hepatocellular carcinoma? A clinical challenge.

Kim R, Byrne MT, Tan A, Aucejo F. Kim R, et al. Among authors: tan a. Oncology (Williston Park). 2011 Mar;25(3):283-91, 295. Oncology (Williston Park). 2011. PMID: 21548473 Free article. Review.

3

Is there a role for adjuvant treatment after hepatic resection for hepatocellular carcinoma?

Tan A, Aucejo F, Kim R. Tan A, et al. Oncology. 2010;78(3-4):161-71. doi: 10.1159/000315577. Epub 2010 Jun 8. Oncology. 2010. PMID: 20530972 Review.

4

Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic liver transplantation.

Kim R, El-Gazzaz G, Tan A, Elson P, Byrne M, Chang YD, Aucejo F. Kim R, et al. Among authors: tan a. Oncology. 2010;79(1-2):62-6. doi: 10.1159/000319548. Epub 2010 Nov 11. Oncology. 2010. PMID: 21071991

5

Serum vascular endothelial growth factor level in patients with hepatocellular carcinoma undergoing liver transplantation: experience of a single Western center.

Tan A, Kim R, El-Gazzaz G, Menon N, Aucejo F. Tan A, et al. Int J Organ Transplant Med. 2012;3(1):42-51. Int J Organ Transplant Med. 2012. PMID: 25013622 Free PMC article.

6

Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation.

Zhang W, Kim R, Quintini C, Hashimoto K, Fujiki M, Diago T, Eghtesad B, Miller C, Fung J, Tan A, Menon KV, Aucejo F. Zhang W, et al. Among authors: tan a. Liver Transpl. 2015 Jan;21(1):101-11. doi: 10.1002/lt.24013. Liver Transpl. 2015. PMID: 25283528 Free article.

7

A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators.

Kim R, Tsao R, Tan A, Byrne M, Almhanna K, Lazaryan A, Elson P, Pelley RJ. Kim R, et al. Among authors: tan a. J Gastrointest Surg. 2010 Jul;14(7):1159-69. doi: 10.1007/s11605-010-1213-z. Epub 2010 May 6. J Gastrointest Surg. 2010. PMID: 20446118

8

Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer.

Kim R, Tan A, Lai KK, Jiang J, Wang Y, Rybicki LA, Liu X. Kim R, et al. Among authors: tan a. Cancer. 2011 Jul 15;117(14):3126-34. doi: 10.1002/cncr.25883. Epub 2011 Jan 24. Cancer. 2011. PMID: 21264835 Free article.

9

Geographic differences in approach to advanced gastric cancer: Is there a standard approach?

Kim R, Tan A, Choi M, El-Rayes BF. Kim R, et al. Among authors: tan a. Crit Rev Oncol Hematol. 2013 Nov;88(2):416-26. doi: 10.1016/j.critrevonc.2013.05.007. Epub 2013 Jun 10. Crit Rev Oncol Hematol. 2013. PMID: 23764501 Review.

10

Controversies in the management of early-stage germ cell tumors.

Tan A, Gilligan T. Tan A, et al. Curr Oncol Rep. 2009 May;11(3):235-43. doi: 10.1007/s11912-009-0033-3. Curr Oncol Rep. 2009. PMID: 19336016 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,971 results

Search Page

Filters